HUMA Humacyte, Inc.
Healthcare$1.05+2.94%OpenMarket Cap: $176.4M
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$3.00
Target (Median)
$3.00
Target Range
$3.00 - $3.00
Upside from current price: 185.7%
Rating Distribution
2 Strong Buy4 Buy1 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-14 | TD Cowen | maintain | Buy | Buy |
| 2026-05-13 | BTIG | maintain | Buy | Buy |
| 2026-04-28 | D. Boral Capital | maintain | Buy | Buy |
| 2026-04-08 | Barclays | maintain | Overweight | Overweight |
| 2026-03-31 | Benchmark | maintain | Speculative Buy | Buy |
| 2026-03-30 | TD Cowen | maintain | Buy | Buy |
| 2026-03-30 | Piper Sandler | maintain | Neutral | Neutral |
| 2026-03-27 | BTIG | maintain | Buy | Buy |
| 2026-03-27 | D. Boral Capital | maintain | Buy | Buy |
| 2026-02-19 | D. Boral Capital | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Thu Dec 31 | $-0.45 | $23.5M | 4 |
| Fri Dec 31 | $-0.22 | $52.6M | 4 |
| Sun Dec 31 | $0.23 | $221.0M | 5 |
| Mon Dec 31 | $1.07 | $440.3M | 1 |